| 000 | 01514 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517081132.0 | ||
| 264 | 0 | _c20170831 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1476-5594 | ||
| 024 | 7 |
_a10.1038/onc.2016.10 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Z-M | |
| 245 | 0 | 0 |
_aPygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway. _h[electronic resource] |
| 260 |
_bOncogene _c09 2016 |
||
| 300 |
_a4787-97 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xgenetics |
| 650 | 0 | 4 | _aMCF-7 Cells |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeoplastic Stem Cells _xmetabolism |
| 650 | 0 | 4 |
_aTranscriptional Activation _xdrug effects |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aWu, J-F | |
| 700 | 1 | _aLuo, Q-C | |
| 700 | 1 | _aLiu, Q-F | |
| 700 | 1 | _aWu, Q-W | |
| 700 | 1 | _aYe, G-D | |
| 700 | 1 | _aShe, H-Q | |
| 700 | 1 | _aLi, B-A | |
| 773 | 0 |
_tOncogene _gvol. 35 _gno. 36 _gp. 4787-97 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/onc.2016.10 _zAvailable from publisher's website |
| 999 |
_c25732352 _d25732352 |
||